H. R. 1193 
One Hundred Seventeenth Congress 
of the 
United States of America 
AT THE SECOND SESSION 
Begun and held at the City of Washington on Monday, 
the third day of January, two thousand and twenty-two 
An Act 
To amend title IV of the Public Health Service Act to direct the Director of the 
National Institutes of Health, in consultation with the Director of the National 
Heart, Lung, and Blood Institute, to establish a program under which the Director 
of the National Institutes of Health shall support or conduct research on valvular 
heart disease, and for other purposes. 
Be it enacted by the Senate and House of Representatives of 
the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Cardiovascular Advances in 
Research and Opportunities Legacy Act’’. 
SEC. 2. HHS VALVULAR HEART DISEASE ACTIVITIES. 
(a) IN GENERAL.—The Secretary of Health and Human Services 
(referred to in this section as the ‘‘Secretary’’) shall, as appropriate, 
continue activities related to research, education, and awareness 
of valvular heart diseases. 
(b) NIH RESEARCH RELATED TO VALVULAR HEART DISEASES.— 
(1) IN GENERAL.—The Director of the National Institutes 
of Health, in consultation with the Director of the National 
Heart, Lung, and Blood Institute, may support or conduct 
research regarding valvular heart diseases. 
(2) SUPPORT
FURTHER
RESEARCH.—In order to improve 
information on, and understanding of, causation and risk fac-
tors for valvular heart diseases, research conducted or sup-
ported under this subsection for such diseases may include 
the following: 
(A) Use of advanced technological imaging and other 
relevant methods to generate data related to valvular heart 
diseases. 
(B) Assessing potential risk factors for sudden cardiac 
arrest or sudden cardiac death from valvular heart dis-
eases. 
(C) Other activities, as appropriate, in order to improve 
the availability of information on, and advance research 
related to, valvular heart diseases. 
(3) MITRAL VALVE PROLAPSE WORKSHOP.—Not later than 
2 years after the date of enactment of this Act, the Director 
of the National Heart, Lung, and Blood Institute shall, as 
appropriate, convene a workshop composed of subject matter 
experts and stakeholders to identify research needs and 
opportunities to develop recommendations for the identification 
and treatment of individuals with mitral valve prolapse,
H. R. 1193—2 
including such individuals who may be at risk for sudden 
cardiac arrest or sudden cardiac death. 
(c) PREVENTION ACTIVITIES TO IMPROVE AWARENESS OF SUDDEN 
CARDIAC DEATH AS A RESULT OF VALVULAR HEART DISEASES.— 
(1) IN GENERAL.—The Secretary may carry out activities 
to increase education and awareness of valvular heart diseases 
in order to reduce the incidence of sudden cardiac death caused 
by such diseases. The Secretary may— 
(A) award grants or contracts to public or nonprofit 
private entities to carry out activities under this subsection; 
and 
(B) directly, or through grants or contracts, provide 
technical assistance with respect to such activities. 
(2) CERTAIN
ACTIVITIES.—Upon availability of applicable 
data, projects carried out under paragraph (1) may include— 
(A) continuing activities at the Centers for Disease 
Control and Prevention related to valvular heart diseases; 
(B) improving the awareness of the public concerning 
any risk factors for, the symptoms of, and the public health 
impact of, valvular heart diseases; and 
(C) enhancing public health data collection and 
improving the quality of such data, as appropriate, 
regarding cardiac arrests, including cardiac arrests that 
occur outside of the hospital. 
(3) 
GRANT
PRIORITIZATION.—The 
Secretary 
may, 
in 
awarding grants or entering into contracts pursuant to para-
graph (1), give priority to entities seeking to carry out projects 
for populations most impacted by valvular heart diseases. 
(4) COORDINATION OF ACTIVITIES.—The Secretary shall, as 
appropriate, ensure that activities under this section are coordi-
nated with other agencies and offices of the Department of 
Health and Human Services that carry out activities regarding 
valvular heart diseases. 
(5) BEST PRACTICES.—The Secretary shall, as applicable 
and appropriate, identify and disseminate best practices for 
relevant health care providers related to valvular heart dis-
eases.
H. R. 1193—3 
(d) AUTHORIZATION OF APPROPRIATIONS.—For purposes of car-
rying out this section, there are authorized to be appropriated 
$28,000,000 for each of fiscal years 2023 through 2027. 
Speaker of the House of Representatives. 
Vice President of the United States and
President of the Senate.